April 5–6, 2020
Hoppe-Seyler-Str. 3
72076 Tübingen
Germany
M.H. at 1, 8 and 30 months, before and after TPP treatment

Dear Colleagues, dear Guests,

Following the first meeting in Utrecht, NL, and the second in Toronto, Canada, the Tübingen team took up the challenge of hosting the third International Consensus Meeting on Robin Sequence (RS) in Tübingen, Germany.

As true for many rare conditions, treatment approaches for Robin Sequence vary considerably, as randomized controlled trials are difficult to perform. Evidence for different treatments, however, can also be based on cohort studies. This requires agreement on the relevant outcomes tested in such studies, i.e. the definition of a common data set to be used in future clinical studies on Robin Sequence.

The latter will be the main subject during the upcoming 3rd international Robin Sequence meeting. We expect renowned speakers from around the world to present their latest data with a focus on a quantification of sleep-related upper airway obstruction and failure to thrive as the two most relevant early outcomes in RS. Also, is there mandibular catch-up growth in RS? What is the long-term outcome and quality-of-life after the various interventions used, and what do parents think?

Whichever approach is being taken, RS treatment requires a team approach, and this is not only reflected by our organizing committee, but also by the faculty of this meeting.

Tübingen is an old medieval university town (the university was founded in 1492) located in the beautiful south-west of Germany. In this region weather conditions can already be quite pleasant in April.

We are looking forward to welcoming you to Tübingen!

Program and Speakers

Program and Speakers (PDF)

Registration

Register

Tourist Information

Bürger- und Verkehrsverein Tübingen e.V.

Sponsor

Directions

Universitätsklinikum
Schnarrenberg
Crona Kliniken
Großer Hörsaal 210
Hoppe-Seyler-Straße 3
72076 Tübingen
Germany